WHO Working Group on Technical Specifications for Manufacture and Evaluation of Yellow Fever Vaccines, Geneva, Switzerland, 13–14 May 2009
Authors:
- Jinho ShinJSJinho Shin
- Ivana KnezevicIvana Knezevic
- Philip MinorPMPhilip Minor
- Alan BarrettABAlan Barrett
- 1 December 2010
- Vol. 28 (52) , 8236-8245
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- A Mouse Model for Studying Viscerotropic Disease Caused by Yellow Fever Virus InfectionPLOS Pathogens, 2009
- Yellow fever vaccine induces integrated multilineage and polyfunctional immune responsesJournal of Experimental Medicine, 2008
- Adverse event reports following yellow fever vaccinationVaccine, 2008
- Case of Yellow Fever Vaccine–Associated Viscerotropic Disease with Prolonged Viremia, Robust Adaptive Immune Responses, and Polymorphisms in CCR5 and RANTES GenesThe Journal of Infectious Diseases, 2008
- Immune Response during Adverse Events after 17D‐Derived Yellow Fever Vaccination in EuropeThe Journal of Infectious Diseases, 2008
- WHO Study Group on cell substrates for production of biologicals, Geneva, Switzerland, 11–12 June 2007Biologicals, 2008
- Molecular and phenotypic analysis of a working seed lot of yellow fever virus 17DD vaccine strain produced from the secondary seed lot 102/84 with an additional passage in chicken embryosBiologicals, 2006
- IABs scientific workshop on neurovirulence tests for live virus vaccines, January 31–February 1, 2005, GenevaBiologicals, 2006
- Characterization of a viscerotropic yellow fever vaccine variant from a patient in BrazilVaccine, 2006
- Viscerotropic and neurotropic disease following vaccination with the 17D yellow fever vaccine, ARILVAX®Vaccine, 2004